COLORECTAL CANCER: SERVIER AND CELSIUS THERAPEUTICS COLLABORATE FOR TARGET DISCOVERY
Dec 21, 2020
Servier and Celsius Therapeutics announced a strategic collaboration focused on the identification and validation of novel colorectal cancer (CRC) drug targets.